Abstract | OBJECT: The central role of endothelin (ET)-1 in the development of cerebral vasospasm after subarachnoid hemorrhage is indicated by the successful treatment of this vasospasm in several animal models by using selective ET(A) receptor antagonists. Clazosentan is a selective ET(A) receptor antagonist that provides for the first time clinical proof that ET-1 is involved in the pathogenesis of cerebral vasospasm. The aim of the present investigation was, therefore, to define the pharmacological properties of clazosentan that affect ET(A) receptor-mediated contraction in the cerebrovasculature. METHODS: Isometric force measurements were performed in rat basilar artery (BA) ring segments with (E+) and without (E-) endothelial function. Concentration effect curves (CECs) were constructed by cumulative application of ET-1 or big ET-1 in the absence or presence of clazosentan (10(-9), 10(-8), and 10(-7) M). The inhibitory potency of clazosentan was determined by the value of the affinity constant (pA2). The CECs for contraction induced by ET-1 and big ET-1 were shifted to the right in the presence of clazosentan in a parallel dose-dependent manner, which indicates competitive antagonism. The pA2 values for ET-1 were 7.8 (E+) and 8.6 (E-) and the corresponding values for big ET-1 were 8.6 (E+) and 8.3 (E-). CONCLUSIONS: The present data characterize clazosentan as a potent competitive antagonist of ET(A) receptor-mediated constriction of the cerebrovasculature by ET-1 and its precursor big ET-1. These functional data may also be used to define an in vitro profile of an ET receptor antagonist with a high probability of clinical efficacy.
|
Authors | Hartmut Vatter, Michael Zimmermann, Veronika Tesanovic, Andreas Raabe, Lothar Schilling, Volker Seifert |
Journal | Journal of neurosurgery
(J Neurosurg)
Vol. 102
Issue 6
Pg. 1101-7
(Jun 2005)
ISSN: 0022-3085 [Print] United States |
PMID | 16028770
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Endothelin A Receptor Antagonists
- Peptides
- Receptor, Endothelin A
|
Topics |
- Animals
- Basilar Artery
(drug effects, physiology)
- Dose-Response Relationship, Drug
- Endothelin A Receptor Antagonists
- In Vitro Techniques
- Male
- Peptides
(pharmacology)
- Rats
- Rats, Sprague-Dawley
- Receptor, Endothelin A
(metabolism)
- Vasoconstriction
(drug effects)
- Vasospasm, Intracranial
(drug therapy)
|